The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2000 participants.
Also called NCT06763055
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 2,000 participants
- Registry
-
NCT06763055
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, China
- Registry status
- Recruiting
Technical summary
Registry record NCT06763055. Randomized; single masking; primary purpose treatment. Start 2025-02-27 (actual); primary completion 2028-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL
- Acronym
- INTERACT5
- Condition
- Intracerebral Hemorrhage
- Condition
- Spontaneous Intracerebral Hemorrhage
- Condition
- Supratentorial Intracerebral Haemorrhage
- Condition
- Acute Intracerebral Haemorrhage
- Condition
- Acute Stroke
- Intervention (Drug)
- Colchicine 0.5 mg
- Intervention (Drug)
- Deferoxamine Mesylate
- Intervention (Other)
- Control (Standard treatment)
- Lead sponsor
- The George Institute
- Collaborator
- University of Calgary
Record details
- Record id
cardio:ct-nct06763055- Content hash
e046386cf419c2c81301e0a57b1b0f3d16bdce9677eb60e1e9d76cfa8e58f747